SHARON TALBERT: Open Payments
NPI 1205482908 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 45 payments from 11 companies in 2025. Trend: 2023 $404 · 2024 $904 · 2025 $1,000
Food & beverage: $1,000
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $188 |
| Collegium Pharmaceutical, Inc. | 12 | $178 |
| Boston Scientific Corporation | 7 | $154 |
| Amgen Inc. | 1 | $124 |
| ABBVIE INC. | 5 | $90 |
| PFIZER INC. | 3 | $63 |
| Nalu Medical, Inc. | 4 | $52 |
| Vertex Pharmaceuticals Incorporated | 2 | $46 |
| Valinor Pharma, LLC | 2 | $39 |
| Bioventus LLC | 1 | $34 |
Products named: RELISTOR, XTAMPZA, KRYSTEXXA, Intracept, UBRELVY, NURTEC ODT, Nalu Neurostimulation System, JOURNAVX.
Industry payments across TX — which companies pay providers there.
